Boxer Capital Management’s Arvinas ARVN Stock Holding History

Boxer Capital Management’s Portfolio ARVN Stock Details ARVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,058,614	Closed	-$20.3M	–	30
2024 Q4	$20.3M	Buy	+1,058,614	New	+$25.7M	1.73%	18

Other funds holding ARVN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Boxer Capital Management's ARVN Position: Q1 2025 in Review

Boxer Capital Management sold out of Arvinas (ARVN) in Q1 2025, closing a stake of 1,058,614 shares — an estimated $20.3M sold.

Boxer Capital Management first reported a position in ARVN in Q4 2024 and held it in 1 quarter. The position peaked at $20.3M in Q4 2024. 215 funds tracked by Wall St. Rank hold ARVN as of Q1 2025.

Boxer Capital Management reported no remaining Arvinas position as of Q1 2025 after selling out during the quarter.
Boxer Capital Management sold 1,058,614 Arvinas shares in Q1 2025, an estimated $20.3M.
Boxer Capital Management first reported a position in Arvinas in Q4 2024 and held it in 1 quarter.
Boxer Capital Management's Arvinas position peaked at $20.3M in Q4 2024.
215 funds tracked by Wall St. Rank held Arvinas as of Q1 2025.

Based on Boxer Capital Management's 13F filing for Q1 2025, filed 15 May 2025.